Roche lamifiban/heparin arm shows 30% decrease in death/MI at six months; no effect seen at 30-day endpoint.
Executive Summary
ROCHE LAMIFIBAN PLUS HEPARIN REDUCES DEATH/MI INCIDENCE 30% AT SIX MONTHS, F. Van de Werf, University Hospital (Leuven, Belgium), said during a symposium on glycoprotein IIb/IIIa receptor antagonists in unstable angina at the European Society of Cardiology meeting in Stockholm Aug. 25. A combination of 300 mcg lamifiban with heparin produced a "statistically significant 30% reduction" of death or myocardial infarction in unstable angina patients, Van de Werf stated.